• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。

Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

机构信息

Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.

DOI:10.1126/science.1197410
PMID:21097933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058422/
Abstract

Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.

摘要

多巴胺通过大脑中多巴胺 G 蛋白偶联受体的激活来调节运动、认知和情绪。人源多巴胺 D3 受体(D3R)与小分子 D2R/D3R 特异性拮抗剂埃替利罗复合物的晶体结构揭示了配体结合口袋和细胞外环的重要特征。在受体的细胞内侧,观察到离子锁的锁定构象和细胞内环 2 的两种截然不同的构象。D3R 选择性拮抗剂 R-22 的对接揭示了埃替利罗结合位点的细胞外延伸,该延伸包含了 R-22 的芳酰胺的第二个结合口袋,该口袋在高度同源的 D2R 和 D3R 之间存在差异。这种差异为设计用于治疗药物滥用和其他神经精神疾病的 D3R 选择性药物提供了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/032f50cc944c/nihms247444f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/19d539defdc8/nihms247444f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/a20bfba58f46/nihms247444f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/881452f9ed1a/nihms247444f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/032f50cc944c/nihms247444f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/19d539defdc8/nihms247444f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/a20bfba58f46/nihms247444f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/881452f9ed1a/nihms247444f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826e/3058422/032f50cc944c/nihms247444f4.jpg

相似文献

1
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.
2
Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.多巴胺 D2 和 D3 受体的不同非活性构象对应于不同程度的反向激动作用。
Elife. 2020 Jan 27;9:e52189. doi: 10.7554/eLife.52189.
3
A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.细胞外 loop 1 中的单个甘氨酸是多巴胺 D2 和 D3 受体药理学特异性的关键决定因素。
Mol Pharmacol. 2013 Dec;84(6):854-64. doi: 10.1124/mol.113.087833. Epub 2013 Sep 23.
4
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.基于依替必利和多巴胺D3受体晶体结构的高选择性多巴胺D3受体拮抗剂和部分激动剂:阿片类药物依赖治疗的新先导化合物
J Med Chem. 2016 Aug 25;59(16):7634-50. doi: 10.1021/acs.jmedchem.6b00860. Epub 2016 Aug 10.
5
Progress in the structural prediction of G protein-coupled receptors: D3 receptor in complex with eticlopride.G 蛋白偶联受体结构预测的进展:与依替唑仑结合的 D3 受体。
Proteins. 2011 Jun;79(6):1695-703. doi: 10.1002/prot.23021. Epub 2011 Apr 12.
6
Selectivity and activation of dopamine D3R from molecular dynamics.从分子动力学角度选择和激活多巴胺 D3R。
J Mol Model. 2012 Dec;18(12):5051-63. doi: 10.1007/s00894-012-1509-x. Epub 2012 Jul 3.
7
Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.一系列[4-(4-羧酰胺基丁基)]-1-芳基哌嗪的设计、合成及构效关系研究:对多巴胺D3与D2受体亚型选择性相关结构特征的深入了解
J Med Chem. 2014 Aug 28;57(16):7042-60. doi: 10.1021/jm500801r. Epub 2014 Aug 15.
8
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.多巴胺 D3 受体拮抗剂揭示了胺能 GPCR 中的一个隐匿口袋。
Sci Rep. 2018 Jan 17;8(1):897. doi: 10.1038/s41598-018-19345-7.
9
Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors.多巴胺D2和D3受体中Na⁺敏感性的结构基础。
Chem Commun (Camb). 2015 May 21;51(41):8618-21. doi: 10.1039/c5cc02204e.
10
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D/D Receptor Bitopic Ligands.一系列基于依托必利的多巴胺 D2/D3 受体双位点配体的构效关系
J Med Chem. 2021 Oct 28;64(20):15313-15333. doi: 10.1021/acs.jmedchem.1c01353. Epub 2021 Oct 12.

引用本文的文献

1
Temporal Features of Gamma Activity of Hyper-direct Pathway Regulated by Dopamine Receptors in the Dyskinetic Rat.异动症大鼠中多巴胺受体调节的超直接通路γ活动的时间特征
Neurosci Bull. 2025 Aug 25. doi: 10.1007/s12264-025-01470-9.
2
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D Dopamine Receptor.D型多巴胺受体新型正变构调节剂-拮抗剂的发现、表征及优化
J Med Chem. 2025 Aug 14;68(15):16691-16749. doi: 10.1021/acs.jmedchem.5c01585. Epub 2025 Aug 1.
3
AI meets physics in computational structure-based drug discovery for GPCRs.在基于计算结构的G蛋白偶联受体药物发现中,人工智能与物理学相遇。
NPJ Drug Discov. 2025;2(1):16. doi: 10.1038/s44386-025-00019-0. Epub 2025 Jul 3.
4
Locomotor activity depends on β-arrestin recruitment by the dopamine D receptor in the striatal D-D receptor heteromer.运动活性取决于纹状体D2-D3受体异聚体中多巴胺D3受体对β-抑制蛋白的招募。
Pharmacol Res. 2025 Aug;218:107826. doi: 10.1016/j.phrs.2025.107826. Epub 2025 Jun 14.
5
A Self-Consistent Approach to Rotamer and Protonation State Assignments (RAPA): Moving Beyond Single Protein Configurations.一种用于旋转异构体和质子化状态分配的自洽方法(RAPA):超越单一蛋白质构型
J Chem Inf Model. 2025 Jul 28;65(14):7639-7650. doi: 10.1021/acs.jcim.5c00859. Epub 2025 Jun 11.
6
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D Receptor.鉴定多巴胺D受体正变构调节剂的脂质暴露螺旋外结合位点
ACS Chem Neurosci. 2025 Jun 18;16(12):2295-2311. doi: 10.1021/acschemneuro.5c00105. Epub 2025 May 15.
7
2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as DR-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies.作为用于三维定量构效关系、对接和分子动力学模拟研究的多巴胺D2受体选择性配体的2-苯基环丙基甲胺(PCPMA)衍生物
Int J Mol Sci. 2025 Apr 10;26(8):3559. doi: 10.3390/ijms26083559.
8
Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light.用于用光研究和控制多巴胺能神经传递的分子工具。
Med Res Rev. 2025 Sep;45(5):1407-1422. doi: 10.1002/med.22112. Epub 2025 Apr 10.
9
Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics.受小檗碱启发的可电离脂质,用于核酸治疗药物的自结构稳定和脑靶向递送。
Nat Commun. 2025 Mar 10;16(1):2368. doi: 10.1038/s41467-025-57488-0.
10
A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs.机器学习算法提示了针对特定 GPCR 靶向的再利用机会。
Int J Mol Sci. 2024 Sep 23;25(18):10230. doi: 10.3390/ijms251810230.

本文引用的文献

1
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors.四氢异喹啉衍生物 SB269,652 是一种多巴胺 D3 和 D2 受体的变构拮抗剂。
Mol Pharmacol. 2010 Nov;78(5):925-34. doi: 10.1124/mol.110.065755. Epub 2010 Aug 11.
2
Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.当前对选择性多巴胺 D(3)受体拮抗剂作为成瘾和相关障碍的药物治疗的看法。
Ann N Y Acad Sci. 2010 Feb;1187:4-34. doi: 10.1111/j.1749-6632.2009.05149.x.
3
N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.具有功能化连接链的N-(4-(4-(2,3-二氯或2-甲氧基苯基)哌嗪-1-基)丁基)杂二芳基羧酰胺,作为高亲和力和对映选择性D3受体拮抗剂。
J Med Chem. 2009 Apr 23;52(8):2559-70. doi: 10.1021/jm900095y.
4
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.β2肾上腺素能受体两种不同失活构象的鉴定协调了结构与生化观察结果。
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94. doi: 10.1073/pnas.0811065106. Epub 2009 Mar 3.
5
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.与拮抗剂结合的人A2A腺苷受体的2.6埃晶体结构。
Science. 2008 Nov 21;322(5905):1211-7. doi: 10.1126/science.1164772. Epub 2008 Oct 2.
6
Dopamine D2 receptors form higher order oligomers at physiological expression levels.多巴胺D2受体在生理表达水平上形成高阶寡聚体。
EMBO J. 2008 Sep 3;27(17):2293-304. doi: 10.1038/emboj.2008.153.
7
Structure of a beta1-adrenergic G-protein-coupled receptor.β1-肾上腺素能G蛋白偶联受体的结构
Nature. 2008 Jul 24;454(7203):486-91. doi: 10.1038/nature07101. Epub 2008 Jun 25.
8
Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors.“A类七螺旋受体中螺旋间氢键网络‘离子锁’的功能作用”
J Mol Biol. 2008 Jul 18;380(4):648-55. doi: 10.1016/j.jmb.2008.05.022. Epub 2008 May 17.
9
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.人β2-肾上腺素能受体2.8埃的结构确定了一个特定的胆固醇结合位点。
Structure. 2008 Jun;16(6):897-905. doi: 10.1016/j.str.2008.05.001.
10
Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure.通过对GPCR结构中的关键残基Glu122(3.41)进行诱变来稳定人β2 - 肾上腺素能受体TM4 - TM3 - TM5螺旋界面
J Mol Biol. 2008 Mar 7;376(5):1305-19. doi: 10.1016/j.jmb.2007.12.028. Epub 2007 Dec 23.